PharmaEssentia Corporation: Clarification on Media Reports

1. Date of Event: June 18, 2026 2. Company Name: PharmaEssentia Corporation 3. Relationship with Company: Parent Company 4. Cross-shareholding Ratio: Not applicable 5. Media Outlet: China Times Business News 6. Report Content: On June 18, 2026, China Times Business News reported: 'Analysts estimate annual revenue could exceed NT$20 billion, setting a new record, with profits surpassing two times earnings per share, potentially making the company the most profitable in the biotech sector.' 7. Reason for Disclosure: Clarification on media reports 8. Response Measures: The company has not released any forward-looking financial or business forecasts. The financial projections regarding the company published by China Times Business News are entirely based on media and analyst speculation. For accurate financial and business information, please refer to disclosures on the 'Public Information Observation Station.' 9. Other Matters to Note: New drug development involves long timelines, high investment costs, and no guarantee of success, which may expose investors to risks. Investors should carefully assess and proceed with caution. Keyword: Material Information